Caffeine, theophylline, and active bronchospasm before a regadenoson perfusion study
A 62-year-old man with known coronary artery disease and COPD is scheduled for a regadenoson stress myocardial perfusion study at 16:00 as a same-day add-on. At check-in he mentions two large cups of coffee at 06:00 and a cola at 11:00. His medications are theophylline 300 mg twice daily (last dose 21:00 the previous evening), tiotropium and prednisone 10 mg daily. He had a COPD exacerbation three weeks ago and still wheezes when climbing stairs; his FEV1 is 52% of predicted. He has been NPO since midnight. Resting heart rate is 58 bpm, blood pressure 138/84 mmHg, and the rhythm is sinus with no AV block. The ordering service wants the study finished today because the patient flies abroad tomorrow for two months and will be unavailable for follow-up.
1. Would you give regadenoson to this patient today? Justify your decision using the pharmacology of each confounding factor.
Read the worked answer
No. Three separate problems make a regadenoson study today uninterpretable and unnecessarily risky.
Caffeine. Methylxanthines are competitive antagonists at adenosine receptors. A 10-hour interval is inside the usual 12-hour minimum and well inside the conservative 24-hour window many laboratories use. Residual caffeine will blunt the A2A-mediated vasodilation and can produce a false-negative perfusion study.
Theophylline. The last dose was about 19 hours ago. With a half-life of roughly 6 to 12 hours, that is only one to three half-lives; five half-lives (two to three days) are needed to clear the drug. Theophylline is also an adenosine antagonist, compounding the caffeine effect.
Active bronchospastic disease. He has a recent exacerbation, ongoing exertional wheeze, and an FEV1 of 52%. Regadenoson can provoke bronchospasm and should be used with caution in bronchoconstrictive disease; a laboratory should not accept that risk electively in a patient who is still symptomatic.
The correct action is to hold the study, document the reasons, and speak directly with the ordering physician rather than proceed with a scan that cannot be trusted.
2. The study is canceled. What is your plan for rescheduling, and what alternatives exist given his travel deadline?
Read the worked answer
Rescheduling requires all three issues addressed: at least 12 hours caffeine-free (many laboratories insist on 24 hours), theophylline withheld for about five half-lives (two to three days) with the prescriber's agreement, and clinical stability of the COPD.
Because he leaves tomorrow, the practical alternative is a different stress modality rather than a different day. Exercise treadmill stress is not blocked by caffeine or theophylline and carries no drug-induced bronchospasm risk, so it is the preferred option if he can exercise to at least 85% of age-predicted maximum heart rate and has no limiting orthopedic or pulmonary problem. His resting heart rate of 58 bpm and sinus rhythm without AV block are favorable for exercise. If he cannot exercise, dobutamine stress is not subject to methylxanthine antagonism and is an alternative, though it is more demanding and has its own arrhythmia risk.
Dipyridamole or adenosine are not good substitutes here, since they share the adenosine-receptor mechanism and the bronchospasm concern. Document the counseling, the caffeine and theophylline history, and the reasoning for the change in plan in the requisition record.
3. Suppose regadenoson had been given and the patient developed acute wheeze. How would you manage it, and what is the specific trap in this patient?
Read the worked answer
Stop and treat as bronchospasm: sit the patient upright, give oxygen, monitor saturation and rhythm, and administer an inhaled short-acting beta-agonist (albuterol nebulizer) while calling for physician support. Regadenoson is given as a single bolus, so there is no infusion to stop, and its effects usually fade over several minutes; supportive care with bronchodilators is often enough.
The trap is aminophylline reversal. The standard rescue for regadenoson or dipyridamole side effects is aminophylline 50 to 125 mg intravenously over about 30 to 60 seconds, but this patient already takes oral theophylline. Adding intravenous aminophylline can push him into theophylline toxicity, with nausea, tachyarrhythmia and seizures. If aminophylline is genuinely required, use the lowest dose, give it slowly, and check a serum theophylline level afterward. This is exactly why the case should never reach that point: the pre-scan medication review exists to prevent a rescue that is itself dangerous. Document the event, the drugs and doses given, and the response.